{
  "ptid_time": "137_S_4596_2012-03-19",
  "img_path": "/data/qiuhui/data/adni/images/137_S_4596/2012-03-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,531 mm³, 11.7% above the reference mean. With a Z-score of 0.28 (60.9th percentile), this represents normal volume ; hippocampal volume measures 5,980 mm³, 25.5% below the reference mean. With a Z-score of -2.55 (0.5th percentile), this represents significant atrophy; whole brain volume measures 1,059,810 mm³, 6.6% below the reference mean. With a Z-score of -0.93 (17.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,368 mm³, 21.0% below the reference mean. With a Z-score of -1.45 (7.3th percentile), this represents mild atrophy; fusiform gyrus volume measures 17,598 mm³, 11.6% below the reference mean. With a Z-score of -0.96 (16.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,032 mm³, 15.1% below the reference mean. With a Z-score of -1.24 (10.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 65.7 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Respiratory; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking. MMSE: 29.0. MoCA: 22.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated); Amyloid beta: 473.80 pg/mL (mild reduced); Total tau: 238.40 pg/mL (normal ); Phosphorylated tau: 23.72 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.55, 0.5th percentile) and mild atrophy in the entorhinal cortex and middle temporal gyrus, which are key regions affected in Alzheimer's disease. Despite normal MMSE (29), the MoCA (22) suggests mild cognitive impairment, and elevated AV45 (amyloid PET) supports amyloid pathology. However, normal CSF Aβ, T-tau, and P-tau levels introduce some uncertainty.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (due to conflicting biomarkers—high amyloid PET but normal CSF markers)",
  "timestamp": "2025-07-26T16:37:20.175360"
}